BioCentury
ARTICLE | Company News

Castle Biosciences, Washington University deal

October 31, 2011 7:00 AM UTC

Castle received exclusive, worldwide rights from the university to IP related to the BRCA1-associated protein 1 (BAP1) gene. Castle will incorporate BAP1 in its DecisionDx-UM assay, which detects the...